229 related articles for article (PubMed ID: 30913037)
1. Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.
Cai NS; Quiroz C; Bonaventura J; Bonifazi A; Cole TO; Purks J; Billing AS; Massey E; Wagner M; Wish ED; Guitart X; Rea W; Lam S; Moreno E; Casadó-Anguera V; Greenblatt AD; Jacobson AE; Rice KC; Casadó V; Newman AH; Winkelman JW; Michaelides M; Weintraub E; Volkow ND; Belcher AM; Ferré S
J Clin Invest; 2019 Mar; 129(7):2730-2744. PubMed ID: 30913037
[TBL] [Abstract][Full Text] [Related]
2. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
[TBL] [Abstract][Full Text] [Related]
3. Opioid-galanin receptor heteromers differentiate the dopaminergic effects of morphine and methadone.
Serafini RA; Zachariou V
J Clin Invest; 2019 May; 129(7):2653-2654. PubMed ID: 31135380
[TBL] [Abstract][Full Text] [Related]
4. Clinical opioids differentially induce co-internalization of μ- and δ-opioid receptors.
Bao F; Li CL; Chen XQ; Lu YJ; Bao L; Zhang X
Mol Pain; 2018; 14():1744806918769492. PubMed ID: 29587571
[TBL] [Abstract][Full Text] [Related]
5. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes.
Bolan EA; Tallarida RJ; Pasternak GW
J Pharmacol Exp Ther; 2002 Nov; 303(2):557-62. PubMed ID: 12388636
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
Wallisch M; Nelson CS; Mulvaney JM; Hernandez HS; Smith SA; Olsen GD
Biochem Pharmacol; 2007 Jun; 73(11):1818-28. PubMed ID: 17343833
[TBL] [Abstract][Full Text] [Related]
7. Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia.
Sánchez-Blázquez P; Gómez-Serranillos P; Garzón J
Brain Res Bull; 2001 Jan; 54(2):229-35. PubMed ID: 11275413
[TBL] [Abstract][Full Text] [Related]
8. Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone.
Levinstein MR; De Oliveira PA; Casajuana-Martin N; Quiroz C; Budinich RC; Rais R; Rea W; Ventriglia EN; Llopart N; Casadó-Anguera V; Moreno E; Walther D; Glatfelter GC; Weinshenker D; Zarate CA; Casadó V; Baumann MH; Pardo L; Ferré S; Michaelides M
Mol Psychiatry; 2024 Mar; 29(3):624-632. PubMed ID: 38145984
[TBL] [Abstract][Full Text] [Related]
9. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
[TBL] [Abstract][Full Text] [Related]
10. Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
Lu Z; Xu J; Rossi GC; Majumdar S; Pasternak GW; Pan YX
J Clin Invest; 2015 Jul; 125(7):2626-30. PubMed ID: 26011641
[TBL] [Abstract][Full Text] [Related]
11. Preferential Gs protein coupling of the galanin Gal
De Oliveira PA; Moreno E; Casajuana-Martin N; Casadó-Anguera V; Cai NS; Camacho-Hernandez GA; Zhu H; Bonifazi A; Hall MD; Weinshenker D; Newman AH; Logothetis DE; Casadó V; Plant LD; Pardo L; Ferré S
Pharmacol Res; 2022 Aug; 182():106322. PubMed ID: 35750299
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
Zhang L; Walker EA; Sutherland J; Young AM
Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
[TBL] [Abstract][Full Text] [Related]
14. Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.
Yang Y; Li Q; He QH; Han JS; Su L; Wan Y
Exp Mol Med; 2018 May; 50(5):1-16. PubMed ID: 29780163
[TBL] [Abstract][Full Text] [Related]
15. Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of
Kapoor A; Provasi D; Filizola M
Mol Pharmacol; 2020 Oct; 98(4):475-486. PubMed ID: 32680919
[TBL] [Abstract][Full Text] [Related]
16. Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain.
Sotgiu ML; Valente M; Storchi R; Caramenti G; Biella GE
Pharmacol Res; 2009 Oct; 60(4):284-90. PubMed ID: 19717013
[TBL] [Abstract][Full Text] [Related]
17. Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.
Bailey CP; Couch D; Johnson E; Griffiths K; Kelly E; Henderson G
J Neurosci; 2003 Nov; 23(33):10515-20. PubMed ID: 14627635
[TBL] [Abstract][Full Text] [Related]
18. Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
Morgan MM; Reid RA; Stormann TM; Lautermilch NJ
J Pain; 2014 Nov; 15(11):1102-1109. PubMed ID: 25106089
[TBL] [Abstract][Full Text] [Related]
19. The biochemical analysis of methadone modulation on morphine-induced tolerance and dependence in the rat brain.
He L; Whistler JL
Pharmacology; 2007; 79(4):193-202. PubMed ID: 17356311
[TBL] [Abstract][Full Text] [Related]
20. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice.
Morinville A; Cahill CM; Esdaile MJ; Aibak H; Collier B; Kieffer BL; Beaudet A
J Neurosci; 2003 Jun; 23(12):4888-98. PubMed ID: 12832511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
